文献速递系统性红斑狼疮其他结缔组织病

全心脏炎与纤维化是狼疮性心肌炎的特征:临床特征、影像学表现与结局

Pancarditis and fibrosis as hallmarks of lupus myocarditis: clinical features, imaging findings and outcomes.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该回顾性队列研究纳入2005–2022年32例狼疮性心肌炎(LM)患者,按年龄和性别1:1匹配活动性SLE无心肌炎(SLE-non-LM)及非自身免疫性急性心肌炎(AM-non-AI)患者。LM患者全心脏炎仅见于LM组(65.6% vs 0%,P<0.001),且ICU入住率和有创机械通气率更高,但2年死亡率与AM-non-AI组相当。

要点

  • LM患者全心脏炎发生率为65.6%,仅见于LM组,AM-non-AI组为0%。
  • LM患者超声示室壁运动异常、左室射血分数降低、肺动脉高压及瓣膜异常均显著高于AM-non-AI组。
  • LM患者ICU入住率和有创机械通气率更高,但2年死亡率与AM-non-AI组相当。

核心结论

  • LM是SLE的一种独特且严重的表型,以全心脏炎和独特影像学特征为特点。
  • 超声心动图和心脏磁共振(CMR)对LM早期识别具有关键作用,并具有预后意义。

研究设计与样本

  • 回顾性队列研究,纳入2005–2022年诊断的32例LM患者,按年龄和性别1:1匹配活动性SLE无心肌炎(SLE-non-LM)及非自身免疫性急性心肌炎(AM-non-AI)患者。
  • SLE患者符合EULAR/ACR 2019标准,临床疑似心肌炎依据欧洲心脏病学会标准,并经CMR(更新版Lake Louise标准)确认。
  • 比较各组临床、实验室、心电图、超声心动图和CMR表现及2年随访结局。

主要发现

  • 与AM-non-AI组相比,LM患者发热和心源性休克发生率更高。
  • 超声心动图显示LM组室壁运动异常(71.9% vs 25.0%,P<0.001)、左室射血分数降低(56.3% vs 18.8%,P=0.002)、肺动脉高压(37.5% vs 3.1%,P=0.001)和瓣膜异常(65.5% vs 3.1%,P<0.001)均显著更常见。
  • CMR显示LM组晚期钆增强(65.6% vs 37.5%,P=0.024)及心包受累和瓣膜反流发生率更高。
  • 全心脏炎仅见于LM患者(65.6% vs 0%,P<0.001)。
  • LM组ICU入住率(28.1% vs 6.3%,P=0.043)和有创机械通气率(25.0% vs 3.1%,P=0.027)更高,但2年死亡率与AM-non-AI组相当。

关键数值与推荐

  • LM诊断依据欧洲心脏病学会临床疑似心肌炎标准,并经CMR更新版Lake Louise标准确认。
  • 全心脏炎在LM组发生率为65.6%,AM-non-AI组为0%(P<0.001)。
  • LM组晚期钆增强发生率为65.6%,AM-non-AI组为37.5%(P=0.024)。

临床怎么用

  • 对SLE患者临床怀疑心肌炎时,应尽早行超声心动图和CMR检查以识别全心脏炎等特征性表现。
  • LM患者病情严重,需警惕心源性休克及ICU入住和有创机械通气需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe and compare the clinical features, imaging findings and outcomes of lupus myocarditis (LM) patients with those of active systemic lupus erythematosus (SLE) without myocarditis (SLE-non-LM) and acute myocarditis non-autoimmune (AM-non-AI) patients. METHODS: This was a retrospective cohort study including 32 LM patients diagnosed between 2005 and 2022, matched 1:1 by age and sex with active SLE-non-LM and AM-non-AI groups. SLE patients (EULAR/ACR 2019) had clinically suspected myocarditis by European Society of Cardiology criteria, confirmed by cardiac magnetic resonance (CMR) imaging (Updated Lake Louise criteria). Clinical, laboratory, electrocardiographic, echocardiographic and CMR findings, as well as outcomes, were compared across groups with a 2-year follow-up. RESULTS: LM patients presented with higher rates of fever and cardiogenic shock compared with AM-non-AI. Echocardiography revealed significantly more wall motion abnormalities (71.9% vs 25.0%, P < 0.001), reduced left ventricular ejection fraction (56.3% vs 18.8%, P = 0.002), pulmonary hypertension (37.5% vs 3.1%, P = 0.001) and valvular abnormalities (65.5% vs 3.1%, P < 0.001). On CMR, LM patients had a higher prevalence of late gadolinium enhancement (65.6% vs 37.5%, P = 0.024) and higher rates of pericardial involvement and valvular regurgitation. Pancarditis was identified exclusively in LM patients (65.6% vs 0%, P < 0.001). Outcomes were worse in LM, with increased ICU admission (28.1% vs 6.3%, P = 0.043) and invasive mechanical ventilation (25.0% vs 3.1%, P = 0.027). However, 2-year mortality was comparable between LM and AM-non-AI groups. CONCLUSION: LM is a distinct and severe phenotype of SLE, characterized by pancarditis and unique imaging features. Echocardiography and CMR are pivotal in early recognition, with prognostic implications.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zamora-Medina MDC, Cimé-Aké E, Godínez-Lazarini E, et al. Pancarditis and fibrosis as hallmarks of lupus myocarditis: clinical features, imaging findings and outcomes. Rheumatology (Oxford). 2026. PMID: 41632493. doi:10.1093/rheumatology/keag067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。